Zions Bancorporation, N.A. Sarepta Therapeutics, Inc. Transaction History

Zions Bancorporation, N.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$69.38 - $86.75 $1,665 - $2,082	-24 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$72.25 - $168.95 $2,167 - $5,068	-30 Reduced 55.56%	24 $2,000
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $2,418 - $4,464	-26 Reduced 32.5%	54 $9,000
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $2,141 - $3,422	26 Added 48.15%	80 $8,000
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $4,132 - $7,321	54 New	54 $7,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

Stay updated on Zions Bancorporation, N.A. with notifications on news.